Abstract
Growth hormone secretagogues (GHSs) represent attractive therapeutic alternatives to recombinant growth hormone (GH), given their ability to amplify pulsatile hormone secretion in a relatively physiologic manner. CP-424,391 (391) is a novel, orally active pyrazolinone-piperidine GHS. In rat pituitary cell cultures, 391 stimulated GH release with an EC50=3 nM. The addition of 391 to rat pituitary cells activated intracellular calcium signaling but did not elevate intracellular cyclic adenosine monophosphate (cAMP). 391 also modulated the effects of GH-releasing hormone and somatostatin on pituitary cell GH-release and intracellular signaling. In nonpituitary cell lines, the ability of 391 to stimulate intracellular signaling was dependent on the expression of recombinant human GHS receptor. Acute administration of 391 to anesthetized rats or to conscious dogs induced pulsatile release of GH in a dose-dependent manner. Plasma insulin-like growth factor-1 (IGF-1) was elevated progressively over a 5-d course of daily oral dosing in dogs. Chronic oral administration of 391 augmented body weight gain in rats and dogs. Thus, the peptidomimetic GHS 391 has potential utility for the treatment of clinical conditions that could benefit from systemic augmentation of GH and IGF-1 levels.
Similar content being viewed by others
References
Iranmanesh, A., Grisso, B., and Veldhuis, J. D. (1994). J. Clin. Endocrinol. Metab. 78, 526–535.
Corpas, E., Harman, S. M., and Blackman, M. R. (1993). Endocr. Rev. 14, 20–39.
Jørgensen, J. O. L., Müller, J., Møller, J., Wolthers, T., Vahl, N., Juul, A., Skakkebæk, N. E., and Christiansen, J. S. (1994). Horm. Res. 42, 235–241.
Ho, K. Y., Evans, W. S., Blizzard, R. M., Veldhuis, J. D., Merriam, G. R., Samojlik, E., Furlanetto, R., Rogol, A. D., Kaiser, D. L., and Thorner, M. O. (1987). J. Clin. Endocrinol. Metab. 64, 51–58.
Jørgensen, J. O., Pedersen, S. A., Thuesen, L., Jorgensen, J., Ingemann-Hansen, T., Skakkebaek, N. E., and Christiansen, J. S. (1989). Lancet 1, 1221–1225.
Salomon, F., Cuneo, R. C., Hesp, R., and Sönksen, P. H. (1989). N. Engl. J. Med. 321, 1797–1803.
Huhn, W. C., Hartman, M. L., Pezzoli, S. S., and Thorner, M. O. (1993). J. Clin. Endocrinol. Metab. 76, 1202–1208.
Aloi, J. A., Gertz, B. J., Hartman, M. L., Huhn, W. C., Pezzoli, S. S., Wittreich, J. M., Krupa, D. A., and Thorner, M. O. (1994) J. Clin. Endocrinol. Metab. 79, 943–949.
Chapman, I. M., Hartman, M. L., Pezzoli, S. S., and Thorner, M. O. (1996). J. Clin. Endocrinol. Metab. 81, 2874–2880.
Bach, M. A., Chapman, I., Farmer, M., Schilling, L., Van Cauter, E., Taylor, A. M., Bolognese, J., Krupa, D., Gormley, G., and Thorner, M. O. (1996). In. The Tenth International Congress of Endocrinology Program & Abstracts. (Endocrine Society: San Francisco.
Bowers, C. Y., Momany, F. A., Reynolds, G. A., and Hong, A. (1984). Endocrinology 114, 1537–1545.
Howard, A. D., Feighner, S. D., Cully, D. F., et al. (1996). Science 273, 974–977.
Smith, R. G., Cheng, K., Schoen, W. R., et al. (1993). Science 260, 1640–1643.
McDowell, R. S., Elias, K. A., Stanley, M. S., et al. (1995). Proc. Natl. Acad. Sci. USA 92, 11165–11169.
Patchett, A. A., Nargund, R. P., Tata, J. R., et al. (1995). Proc. Natl. Acad. Sci. USA 92, 7001–7005.
Lefker, B. A., Carpino, P. A., Pan, L. C., et al. (1998). In: Growth Hormone Secretagogues in Clinical Practice. Bercu, B. B. and Walker, R. F. (eds.). Marcel Dekker: New York.
Bresson-Bepoldin, L. and Dufy-Barbe, L. (1994). Cell. Calcium 15, 247–258.
Poug, S.-S., Chaung, L.-Y. P., Dean, D. C., Nargund, R. P., Patchett, A. A. and Smith, R. G. (1996). Mol. Endocrinol. 10, 57–61.
Smith, R. G., Van der Ploeg, L. H. T., Howard, A. D., Feighner, S. D., Cheng, K., Hickey, G. J., Wyvratt, M. J., Fisher, M. H., Nargund, R. P., and Patchett, A. A. (1997). Endocr. Rev. 18, 621–645.
Chihara, K., Arimura, A., and Schally, A. V. (1979). Endocrinology 104, 1434–1440.
Ong, H., McNicoll, N., Escher, E., Collu, R., Deghenghi, R., Locatelli, V., Ghigo, E., Muccioli, G., Boghen, M., and Nilsson, M. (1998). Endocrinology 139, 432–435.
Bodart, V., Bouchard, J. F., McNicholl, N., Escher, E., Carriere, P., Ghigo, E., Sejlitz, T., Sirois, M. G., Lamontagne, D., and Ong, H. (1999). Circ. Res. 85, 796–802.
Cheng, K., Chan, W. W., Barreto, A. Jr., Convey, E. M., and Smith, R. G. (1989). Endocrinology 124, 2791–2798.
Adams, E. F., Lei, T., Buchfelder, M., Bowers, C. Y., and Fahlbusch, R. (1996). Mol. Endocrinol. 10, 432–438.
Koch, B. D., Blalock, J. B., and Schonbrunn, A. (1988). J. Biol. Chem. 263, 216–225.
Chapman, I. M., Pescovitz, O. H., Murphy, G., Treep, T., Cerchio, K. A., Krupa, D., Gertz, B., Polvino, W. J., Skiles, E. H., Pezzoli, S. S., and Thorner, M. O. (1997). J. Clin. Endocrinol. Metab. 82, 3455–3463.
Locke, W., Kirgis, H. D., Bowers, C. Y., and Abdoh, A. A. (1995). Life Sci. 56, 1347–1352.
Okada, K., Ishii, S., Minami, S., Sugihara, H., Shibasaki, T., and Wakabayashi, I. (1996). Endocrinology 137, 5155–5158.
Murphy, M. G., Plunkett, L. M., Gertz, B. J., He, W., Wittreich, J., Polvino, W. M., and Clemmons, D. R. (1998). J. Clin. Endocrinol. Metab. 83, 320–325.
Svensson, J., Ohlsson, C., Jansson, J. O., Murphy, G., Wyss, D., Krupa, D., Cerchio, K., Polvino, W., Gertz, B., Baylink, D., Mohan, S., and Bengtsson, B. A. (1998). J. Bone Miner. Res. 13, 1158–1166.
Murphy, M. G., Bach, M. A., Plotkin, D., Bolognese, J., Ng, J., Krupa, D., Cerchio, K., and Gertz, B. J. (1999). J. Bone Miner. Res. 14, 1182–1188.
Svensson, J., Lonn, L., Jansson, J. O., Murphy, G., Wyss, D., Krupa, D., Cerchio, K., Polvino, W., Gertz, B., Boseaus, I., Sjostrom, L., and Bengtsson, B. A. (1998). J. Clin. Endocrinol. Metab. 83, 362–369.
Copinschi, G., Leproult, R., Van Onderberger, A., Caufriez, A., Cole, K. Y., Schilling, L. M., Mendel, C. M., de Lepeleire, I., Bolognese, J. A., and Van Cauter, E. (1997), Neuroendocrinology 66, 278–286.
Lieber, R. L., Jacks, T. M., Mohler, R. L., Schleim, K., Haven, M., Cuizon, D., Gershuni, D. H., Lopez, M. A., Hora, D. Jr., Nargund, R., Feeney, W., and Hickey, G. J. (1997). J. Orthop. Res. 15, 519–527.
Bisi, G., Podio, V., Valetto, M. R., Broglio, F., Bertuccio, G., Del Rio, G., Arvat, E., Boghen, M. F., Deghenghi, F., Muccioli, G., Ong, H., and Ghigo, E. (1999). J. Endocrinol. Invest. 22, 266–272.
De Gennaro Colonna, V., Rossoni, G., Bernareggi, M., Muller, E. E., and Berti, F. (1997). Eur. J. Pharmacol. 334, 201–207.
Rossoni, G., De Gennaro Colonna, V., Bernareggi, M., Polvani, G. L., Muller, E. E., and Berti, F. (1998). J. Cardiovasc. Pharm. 32, 260–265.
Locatelli, V., Rossoni, G., Schweiger, F., Torsello, A., De Gennaro Colonna, V., Bernareggi, M., Deghenghi, R., Muller, E. E., and Berti, F. (1999). Endocrinology 140, 4024–4031.
Ke, H. Z., Li, M., Pan, L. C., Yu, L., MacLean, D. B., and Thompson, D. D. (1998). Bone, 23, S390.
Houck, W. V., Pan, L. C., Kribbs, S. B., Clair, M. J., McDaniel, G. M., Krombach, R. S., Merritt, W. M., Pirie, C. M., Iannini, J. P., Mukherjee, R., and Spinale, F. G. (1999). Circulation, 100, 2003–2009.
King, M. K., Gay, D. M., Pan, L. C., McElmurray, J. H., Hendrick, J. W., Pirie, C., Morrison, L., Holloman, M., Mukherjee, R., and Spinale, F. G. Circulation, in press.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pan, L.C., Carpino, P.A., Lefker, B.A. et al. Preclinical pharmacology of CP-424,391, and orally active pyrazolinone-piperidine growth hormone secretagogue. Endocr 14, 121–132 (2001). https://doi.org/10.1385/ENDO:14:1:121
Issue Date:
DOI: https://doi.org/10.1385/ENDO:14:1:121